These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8349950)

  • 1. The effect of two glucan carboxymethyl derivatives with various substitution degrees on cyclophosphamide immunosuppression in mice.
    Wagnerová J; Lísková A; Navarová J; Kristofová A; Trnovec T; Ferencík M
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):227-42. PubMed ID: 8349950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of hematopoiesis in untreated and cyclophosphamide treated mice by the inhibition of prostaglandin synthesis.
    Nikcevich DA; Young MR; Ellis NK; Newby M; Wepsic HT
    J Immunopharmacol; 1986; 8(3):299-313. PubMed ID: 3760591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen.
    Sefc L; Psenák O; Sýkora V; Sulc K; Necas E
    J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low frequency low energy pulsing electromagnetic fields on mice injected with cyclophosphamide.
    Cadossi R; Zucchini P; Emilia G; Franceschi C; Cossarizza A; Santantonio M; Mandolini G; Torelli G
    Exp Hematol; 1991 Mar; 19(3):196-201. PubMed ID: 1995311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis.
    Harnack U; Eckert K; Fichtner I; Pecher G
    In Vivo; 2010; 24(1):59-63. PubMed ID: 20133977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemopoiesis-enhancing effects of repeatedly administered carboxymethylglucan in mice exposed to fractionated irradiation.
    Hofer M; Pospísil M; Pipalová I; Holá J; Sandula J
    Folia Biol (Praha); 1995; 41(5):249-56. PubMed ID: 8714774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of postirradiation carboxymethylglucan administration in mice.
    Hofer M; Pospísil M; Viklická S; Pipalová I; Holá J; Netíková J; Sandula J
    Int J Immunopharmacol; 1995 Mar; 17(3):167-74. PubMed ID: 7558510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclophosphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma.
    Fried W; Kedo A; Barone J
    Cancer Res; 1977 Apr; 37(4):1205-9. PubMed ID: 321118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural changes of stromal cells of bone marrow and liver after cyclophosphamide treatment in mice.
    Anton E
    Tissue Cell; 1997 Feb; 29(1):1-9. PubMed ID: 9061976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment.
    Patchen ML; MacVittie TJ
    Acta Haematol; 1983; 70(5):281-8. PubMed ID: 6414220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin FC; Levin J
    J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of SCG, 1,3-beta-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice.
    Harada T; Miura N; Adachi Y; Nakajima M; Yadomae T; Ohn N
    Biol Pharm Bull; 2002 Jul; 25(7):931-9. PubMed ID: 12132673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
    Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
    Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of suppressor cells in the bone marrow and spleens of high dose cyclophosphamide-treated C57Bl/6 mice.
    Nikcevich DA; Duffie GP; Young MR; Ellis NK; Kaufman GE; Wepsic HT
    Cell Immunol; 1987 Oct; 109(2):349-59. PubMed ID: 2959374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginsenoside Rg1 improves bone marrow haematopoietic activity via extramedullary haematopoiesis of the spleen.
    Liu HH; Chen FP; Liu RK; Lin CL; Chang KT
    J Cell Mol Med; 2015 Nov; 19(11):2575-86. PubMed ID: 26153045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic administration of cyclophosphamide on haemopoietic stem cells.
    Pannacciulli IM; Massa G; Saviane AG; Bianchi G; Bogliolo GV; Ghio R
    Scand J Haematol; 1977 Aug; 19(2):217-23. PubMed ID: 897562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ultrasonicated carboxymethylglucan on cyclophosphamide induced mutagenicity.
    Chorvatovicová D; Machová E; Sandula J
    Mutat Res; 1996 Nov; 371(1-2):115-20. PubMed ID: 8950357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice.
    Tsuzuki A; Tateishi T; Ohno N; Adachi Y; Yadomae T
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):104-10. PubMed ID: 10052129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.